IceCure Medical Ltd
IceCure Medical Ltd ICCM Peers
See (ICCM) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ICCM | $1.02 | +2.46% | 57.7M | -3.64 | -$0.28 | N/A |
| ABT | $134.67 | -0.99% | 237.1B | 17.72 | $7.69 | +1.67% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| BSX | $103.64 | -3.51% | 155B | 76.46 | $1.37 | N/A |
| SYK | $392.08 | -0.90% | 151.6B | 53.68 | $7.39 | +0.84% |
| MDT | $88.50 | +1.52% | 113.7B | 24.58 | $3.61 | +3.18% |
| EW | $76.97 | -1.59% | 45.3B | 31.90 | $2.42 | N/A |
| DXCM | $83.50 | -4.34% | 32.8B | 62.84 | $1.33 | N/A |
| STE | $238.02 | -0.92% | 23.9B | 39.39 | $6.16 | +0.94% |
| PHG | $24.53 | +2.27% | 22.4B | 80.65 | $0.30 | +3.66% |
Stock Comparison
ICCM vs ABT Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, ABT has a market cap of 237.1B. Regarding current trading prices, ICCM is priced at $1.02, while ABT trades at $134.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas ABT's P/E ratio is 17.72. In terms of profitability, ICCM's ROE is -1.82%, compared to ABT's ROE of +0.31%. Regarding short-term risk, ICCM is more volatile compared to ABT. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs BSX-PA Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, ICCM is priced at $1.02, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, ICCM's ROE is -1.82%, compared to BSX-PA's ROE of +0.10%. Regarding short-term risk, ICCM is more volatile compared to BSX-PA. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs BSX Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, BSX has a market cap of 155B. Regarding current trading prices, ICCM is priced at $1.02, while BSX trades at $103.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas BSX's P/E ratio is 76.46. In terms of profitability, ICCM's ROE is -1.82%, compared to BSX's ROE of +0.10%. Regarding short-term risk, ICCM is more volatile compared to BSX. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs SYK Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, SYK has a market cap of 151.6B. Regarding current trading prices, ICCM is priced at $1.02, while SYK trades at $392.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas SYK's P/E ratio is 53.68. In terms of profitability, ICCM's ROE is -1.82%, compared to SYK's ROE of +0.11%. Regarding short-term risk, ICCM is more volatile compared to SYK. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs MDT Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, MDT has a market cap of 113.7B. Regarding current trading prices, ICCM is priced at $1.02, while MDT trades at $88.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas MDT's P/E ratio is 24.58. In terms of profitability, ICCM's ROE is -1.82%, compared to MDT's ROE of +0.10%. Regarding short-term risk, ICCM is more volatile compared to MDT. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs EW Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, EW has a market cap of 45.3B. Regarding current trading prices, ICCM is priced at $1.02, while EW trades at $76.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas EW's P/E ratio is 31.90. In terms of profitability, ICCM's ROE is -1.82%, compared to EW's ROE of +0.49%. Regarding short-term risk, ICCM is more volatile compared to EW. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs DXCM Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, DXCM has a market cap of 32.8B. Regarding current trading prices, ICCM is priced at $1.02, while DXCM trades at $83.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas DXCM's P/E ratio is 62.84. In terms of profitability, ICCM's ROE is -1.82%, compared to DXCM's ROE of +0.24%. Regarding short-term risk, ICCM is more volatile compared to DXCM. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs STE Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, STE has a market cap of 23.9B. Regarding current trading prices, ICCM is priced at $1.02, while STE trades at $238.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas STE's P/E ratio is 39.39. In terms of profitability, ICCM's ROE is -1.82%, compared to STE's ROE of +0.09%. Regarding short-term risk, ICCM is more volatile compared to STE. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs PHG Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, PHG has a market cap of 22.4B. Regarding current trading prices, ICCM is priced at $1.02, while PHG trades at $24.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas PHG's P/E ratio is 80.65. In terms of profitability, ICCM's ROE is -1.82%, compared to PHG's ROE of +0.03%. Regarding short-term risk, ICCM is more volatile compared to PHG. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs PODD Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, PODD has a market cap of 21.1B. Regarding current trading prices, ICCM is priced at $1.02, while PODD trades at $300.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas PODD's P/E ratio is 54.05. In terms of profitability, ICCM's ROE is -1.82%, compared to PODD's ROE of +0.35%. Regarding short-term risk, ICCM is more volatile compared to PODD. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs ZBH Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, ZBH has a market cap of 18.6B. Regarding current trading prices, ICCM is priced at $1.02, while ZBH trades at $93.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas ZBH's P/E ratio is 20.90. In terms of profitability, ICCM's ROE is -1.82%, compared to ZBH's ROE of +0.07%. Regarding short-term risk, ICCM is more volatile compared to ZBH. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs ABMD Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, ICCM is priced at $1.02, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas ABMD's P/E ratio is 65.36. In terms of profitability, ICCM's ROE is -1.82%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, ICCM is more volatile compared to ABMD. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs ALGN Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, ALGN has a market cap of 14.1B. Regarding current trading prices, ICCM is priced at $1.02, while ALGN trades at $195.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas ALGN's P/E ratio is 35.26. In terms of profitability, ICCM's ROE is -1.82%, compared to ALGN's ROE of +0.11%. Regarding short-term risk, ICCM is more volatile compared to ALGN. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs SNN Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, SNN has a market cap of 13.4B. Regarding current trading prices, ICCM is priced at $1.02, while SNN trades at $30.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas SNN's P/E ratio is 32.56. In terms of profitability, ICCM's ROE is -1.82%, compared to SNN's ROE of +0.08%. Regarding short-term risk, ICCM is more volatile compared to SNN. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs SWAV Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, ICCM is priced at $1.02, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas SWAV's P/E ratio is 78.76. In terms of profitability, ICCM's ROE is -1.82%, compared to SWAV's ROE of +0.14%. Regarding short-term risk, ICCM is more volatile compared to SWAV. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs PEN Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, PEN has a market cap of 9.7B. Regarding current trading prices, ICCM is priced at $1.02, while PEN trades at $249.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas PEN's P/E ratio is 232.44. In terms of profitability, ICCM's ROE is -1.82%, compared to PEN's ROE of +0.04%. Regarding short-term risk, ICCM is more volatile compared to PEN. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs GMED Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, GMED has a market cap of 8.1B. Regarding current trading prices, ICCM is priced at $1.02, while GMED trades at $60.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas GMED's P/E ratio is 44.90. In terms of profitability, ICCM's ROE is -1.82%, compared to GMED's ROE of +0.05%. Regarding short-term risk, ICCM is more volatile compared to GMED. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs BIO-B Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, BIO-B has a market cap of 6.8B. Regarding current trading prices, ICCM is priced at $1.02, while BIO-B trades at $250.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas BIO-B's P/E ratio is -3.27. In terms of profitability, ICCM's ROE is -1.82%, compared to BIO-B's ROE of -0.32%. Regarding short-term risk, ICCM is more volatile compared to BIO-B. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs BIO Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, BIO has a market cap of 6.7B. Regarding current trading prices, ICCM is priced at $1.02, while BIO trades at $251.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas BIO's P/E ratio is -3.24. In terms of profitability, ICCM's ROE is -1.82%, compared to BIO's ROE of -0.32%. Regarding short-term risk, ICCM is more volatile compared to BIO. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs BRKR Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, BRKR has a market cap of 6.3B. Regarding current trading prices, ICCM is priced at $1.02, while BRKR trades at $42.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas BRKR's P/E ratio is 80.58. In terms of profitability, ICCM's ROE is -1.82%, compared to BRKR's ROE of +0.04%. Regarding short-term risk, ICCM is more volatile compared to BRKR. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs GKOS Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, GKOS has a market cap of 5.9B. Regarding current trading prices, ICCM is priced at $1.02, while GKOS trades at $104.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas GKOS's P/E ratio is -45.20. In terms of profitability, ICCM's ROE is -1.82%, compared to GKOS's ROE of -0.17%. Regarding short-term risk, ICCM is more volatile compared to GKOS. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs NARI Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, ICCM is priced at $1.02, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas NARI's P/E ratio is -59.24. In terms of profitability, ICCM's ROE is -1.82%, compared to NARI's ROE of -0.18%. Regarding short-term risk, ICCM is more volatile compared to NARI. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs IRTC Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, IRTC has a market cap of 4.7B. Regarding current trading prices, ICCM is priced at $1.02, while IRTC trades at $143.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas IRTC's P/E ratio is -46.78. In terms of profitability, ICCM's ROE is -1.82%, compared to IRTC's ROE of -1.13%. Regarding short-term risk, ICCM is more volatile compared to IRTC. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs TMDX Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, TMDX has a market cap of 4.4B. Regarding current trading prices, ICCM is priced at $1.02, while TMDX trades at $126.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas TMDX's P/E ratio is 91.62. In terms of profitability, ICCM's ROE is -1.82%, compared to TMDX's ROE of +0.22%. Regarding short-term risk, ICCM is more volatile compared to TMDX. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs ITGR Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, ITGR has a market cap of 4.2B. Regarding current trading prices, ICCM is priced at $1.02, while ITGR trades at $121.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas ITGR's P/E ratio is 56.70. In terms of profitability, ICCM's ROE is -1.82%, compared to ITGR's ROE of +0.05%. Regarding short-term risk, ICCM is more volatile compared to ITGR. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs INSP Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, INSP has a market cap of 3.9B. Regarding current trading prices, ICCM is priced at $1.02, while INSP trades at $129.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas INSP's P/E ratio is 59.76. In terms of profitability, ICCM's ROE is -1.82%, compared to INSP's ROE of +0.10%. Regarding short-term risk, ICCM is more volatile compared to INSP. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs AXNX Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, ICCM is priced at $1.02, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas AXNX's P/E ratio is -709.80. In terms of profitability, ICCM's ROE is -1.82%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, ICCM is more volatile compared to AXNX. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs PRCT Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, PRCT has a market cap of 3.1B. Regarding current trading prices, ICCM is priced at $1.02, while PRCT trades at $59.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas PRCT's P/E ratio is -33.47. In terms of profitability, ICCM's ROE is -1.82%, compared to PRCT's ROE of -0.28%. Regarding short-term risk, ICCM is less volatile compared to PRCT. This indicates potentially lower risk in terms of short-term price fluctuations for ICCM.
ICCM vs LIVN Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, LIVN has a market cap of 2.5B. Regarding current trading prices, ICCM is priced at $1.02, while LIVN trades at $45.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas LIVN's P/E ratio is -11.24. In terms of profitability, ICCM's ROE is -1.82%, compared to LIVN's ROE of -0.18%. Regarding short-term risk, ICCM is more volatile compared to LIVN. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs NUVA Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, ICCM is priced at $1.02, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas NUVA's P/E ratio is 75.00. In terms of profitability, ICCM's ROE is -1.82%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, ICCM is more volatile compared to NUVA. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs UFPT Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, UFPT has a market cap of 1.9B. Regarding current trading prices, ICCM is priced at $1.02, while UFPT trades at $245.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas UFPT's P/E ratio is 30.96. In terms of profitability, ICCM's ROE is -1.82%, compared to UFPT's ROE of +0.19%. Regarding short-term risk, ICCM is more volatile compared to UFPT. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs CNMD Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, CNMD has a market cap of 1.7B. Regarding current trading prices, ICCM is priced at $1.02, while CNMD trades at $53.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas CNMD's P/E ratio is 14.19. In terms of profitability, ICCM's ROE is -1.82%, compared to CNMD's ROE of +0.13%. Regarding short-term risk, ICCM is more volatile compared to CNMD. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs ATEC Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, ATEC has a market cap of 1.6B. Regarding current trading prices, ICCM is priced at $1.02, while ATEC trades at $10.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas ATEC's P/E ratio is -9.59. In terms of profitability, ICCM's ROE is -1.82%, compared to ATEC's ROE of -2.58%. Regarding short-term risk, ICCM is more volatile compared to ATEC. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs AORT Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, AORT has a market cap of 1.3B. Regarding current trading prices, ICCM is priced at $1.02, while AORT trades at $30.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas AORT's P/E ratio is -60.26. In terms of profitability, ICCM's ROE is -1.82%, compared to AORT's ROE of -0.07%. Regarding short-term risk, ICCM is more volatile compared to AORT. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs HSKA Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, ICCM is priced at $1.02, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas HSKA's P/E ratio is -62.49. In terms of profitability, ICCM's ROE is -1.82%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, ICCM is more volatile compared to HSKA. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs AHCO Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, AHCO has a market cap of 1.3B. Regarding current trading prices, ICCM is priced at $1.02, while AHCO trades at $9.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas AHCO's P/E ratio is 16.21. In terms of profitability, ICCM's ROE is -1.82%, compared to AHCO's ROE of +0.06%. Regarding short-term risk, ICCM is more volatile compared to AHCO. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs ESTA Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, ESTA has a market cap of 1.3B. Regarding current trading prices, ICCM is priced at $1.02, while ESTA trades at $43.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas ESTA's P/E ratio is -13.91. In terms of profitability, ICCM's ROE is -1.82%, compared to ESTA's ROE of -2.10%. Regarding short-term risk, ICCM is more volatile compared to ESTA. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs TNDM Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, TNDM has a market cap of 1.1B. Regarding current trading prices, ICCM is priced at $1.02, while TNDM trades at $17.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas TNDM's P/E ratio is -6.18. In terms of profitability, ICCM's ROE is -1.82%, compared to TNDM's ROE of -0.83%. Regarding short-term risk, ICCM is more volatile compared to TNDM. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs SILK Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, ICCM is priced at $1.02, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas SILK's P/E ratio is -18.96. In terms of profitability, ICCM's ROE is -1.82%, compared to SILK's ROE of -0.29%. Regarding short-term risk, ICCM is more volatile compared to SILK. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs FNA Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, ICCM is priced at $1.02, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas FNA's P/E ratio is -19.83. In terms of profitability, ICCM's ROE is -1.82%, compared to FNA's ROE of -0.36%. Regarding short-term risk, ICCM is more volatile compared to FNA. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs SSII Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, SSII has a market cap of 1.1B. Regarding current trading prices, ICCM is priced at $1.02, while SSII trades at $5.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas SSII's P/E ratio is -70.75. In terms of profitability, ICCM's ROE is -1.82%, compared to SSII's ROE of -1.33%. Regarding short-term risk, ICCM is less volatile compared to SSII. This indicates potentially lower risk in terms of short-term price fluctuations for ICCM.
ICCM vs INMD Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, INMD has a market cap of 1B. Regarding current trading prices, ICCM is priced at $1.02, while INMD trades at $15.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas INMD's P/E ratio is 6.65. In terms of profitability, ICCM's ROE is -1.82%, compared to INMD's ROE of +0.25%. Regarding short-term risk, ICCM is more volatile compared to INMD. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs IART Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, IART has a market cap of 1B. Regarding current trading prices, ICCM is priced at $1.02, while IART trades at $13.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas IART's P/E ratio is -34.87. In terms of profitability, ICCM's ROE is -1.82%, compared to IART's ROE of -0.03%. Regarding short-term risk, ICCM is more volatile compared to IART. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs CSII Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, ICCM is priced at $1.02, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas CSII's P/E ratio is -20.83. In terms of profitability, ICCM's ROE is -1.82%, compared to CSII's ROE of -0.14%. Regarding short-term risk, ICCM is more volatile compared to CSII. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs SIBN Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, SIBN has a market cap of 780.3M. Regarding current trading prices, ICCM is priced at $1.02, while SIBN trades at $18.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas SIBN's P/E ratio is -29.06. In terms of profitability, ICCM's ROE is -1.82%, compared to SIBN's ROE of -0.16%. Regarding short-term risk, ICCM is more volatile compared to SIBN. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs IRMD Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, IRMD has a market cap of 769.4M. Regarding current trading prices, ICCM is priced at $1.02, while IRMD trades at $61.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas IRMD's P/E ratio is 39.04. In terms of profitability, ICCM's ROE is -1.82%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, ICCM is more volatile compared to IRMD. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs CRY Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, CRY has a market cap of 725.1M. Regarding current trading prices, ICCM is priced at $1.02, while CRY trades at $17.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas CRY's P/E ratio is 425.71. In terms of profitability, ICCM's ROE is -1.82%, compared to CRY's ROE of -0.07%. Regarding short-term risk, ICCM is more volatile compared to CRY. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs CBLL Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, CBLL has a market cap of 671.2M. Regarding current trading prices, ICCM is priced at $1.02, while CBLL trades at $18.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas CBLL's P/E ratio is -14.86. In terms of profitability, ICCM's ROE is -1.82%, compared to CBLL's ROE of -1.64%. Regarding short-term risk, ICCM is more volatile compared to CBLL. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs BFLY-WT Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, BFLY-WT has a market cap of 584.9M. Regarding current trading prices, ICCM is priced at $1.02, while BFLY-WT trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas BFLY-WT's P/E ratio is N/A. In terms of profitability, ICCM's ROE is -1.82%, compared to BFLY-WT's ROE of -0.33%. Regarding short-term risk, ICCM is less volatile compared to BFLY-WT. This indicates potentially lower risk in terms of short-term price fluctuations for ICCM.
ICCM vs APEN Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, ICCM is priced at $1.02, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas APEN's P/E ratio is -9.43. In terms of profitability, ICCM's ROE is -1.82%, compared to APEN's ROE of -0.85%. Regarding short-term risk, ICCM is more volatile compared to APEN. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs AVNS Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, AVNS has a market cap of 577.6M. Regarding current trading prices, ICCM is priced at $1.02, while AVNS trades at $12.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas AVNS's P/E ratio is -1.51. In terms of profitability, ICCM's ROE is -1.82%, compared to AVNS's ROE of -0.37%. Regarding short-term risk, ICCM is more volatile compared to AVNS. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs KIDS Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, KIDS has a market cap of 541.5M. Regarding current trading prices, ICCM is priced at $1.02, while KIDS trades at $22.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas KIDS's P/E ratio is -12.42. In terms of profitability, ICCM's ROE is -1.82%, compared to KIDS's ROE of -0.11%. Regarding short-term risk, ICCM is more volatile compared to KIDS. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs RXST Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, RXST has a market cap of 533.2M. Regarding current trading prices, ICCM is priced at $1.02, while RXST trades at $13.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas RXST's P/E ratio is -19.88. In terms of profitability, ICCM's ROE is -1.82%, compared to RXST's ROE of -0.10%. Regarding short-term risk, ICCM is more volatile compared to RXST. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs AXGN Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, AXGN has a market cap of 499.2M. Regarding current trading prices, ICCM is priced at $1.02, while AXGN trades at $10.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas AXGN's P/E ratio is -68.50. In terms of profitability, ICCM's ROE is -1.82%, compared to AXGN's ROE of -0.07%. Regarding short-term risk, ICCM is more volatile compared to AXGN. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs BFLY Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, BFLY has a market cap of 478.5M. Regarding current trading prices, ICCM is priced at $1.02, while BFLY trades at $1.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas BFLY's P/E ratio is -6.45. In terms of profitability, ICCM's ROE is -1.82%, compared to BFLY's ROE of -0.33%. Regarding short-term risk, ICCM is more volatile compared to BFLY. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs BVS Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, BVS has a market cap of 462.5M. Regarding current trading prices, ICCM is priced at $1.02, while BVS trades at $6.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas BVS's P/E ratio is -14.52. In terms of profitability, ICCM's ROE is -1.82%, compared to BVS's ROE of -0.21%. Regarding short-term risk, ICCM is more volatile compared to BVS. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs CTKB Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, CTKB has a market cap of 440.8M. Regarding current trading prices, ICCM is priced at $1.02, while CTKB trades at $3.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas CTKB's P/E ratio is -38.67. In terms of profitability, ICCM's ROE is -1.82%, compared to CTKB's ROE of -0.03%. Regarding short-term risk, ICCM is less volatile compared to CTKB. This indicates potentially lower risk in terms of short-term price fluctuations for ICCM.
ICCM vs OFIX Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, OFIX has a market cap of 438M. Regarding current trading prices, ICCM is priced at $1.02, while OFIX trades at $11.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas OFIX's P/E ratio is -3.02. In terms of profitability, ICCM's ROE is -1.82%, compared to OFIX's ROE of -0.28%. Regarding short-term risk, ICCM is more volatile compared to OFIX. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs SRDX Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, SRDX has a market cap of 418.7M. Regarding current trading prices, ICCM is priced at $1.02, while SRDX trades at $29.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas SRDX's P/E ratio is -20.91. In terms of profitability, ICCM's ROE is -1.82%, compared to SRDX's ROE of -0.17%. Regarding short-term risk, ICCM is more volatile compared to SRDX. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs SMLR Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, SMLR has a market cap of 395M. Regarding current trading prices, ICCM is priced at $1.02, while SMLR trades at $39.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas SMLR's P/E ratio is -14.82. In terms of profitability, ICCM's ROE is -1.82%, compared to SMLR's ROE of -0.21%. Regarding short-term risk, ICCM is less volatile compared to SMLR. This indicates potentially lower risk in terms of short-term price fluctuations for ICCM.
ICCM vs PACB Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, PACB has a market cap of 387.1M. Regarding current trading prices, ICCM is priced at $1.02, while PACB trades at $1.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas PACB's P/E ratio is -0.47. In terms of profitability, ICCM's ROE is -1.82%, compared to PACB's ROE of -1.70%. Regarding short-term risk, ICCM is less volatile compared to PACB. This indicates potentially lower risk in terms of short-term price fluctuations for ICCM.
ICCM vs TMCI Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, TMCI has a market cap of 378.7M. Regarding current trading prices, ICCM is priced at $1.02, while TMCI trades at $5.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas TMCI's P/E ratio is -7.08. In terms of profitability, ICCM's ROE is -1.82%, compared to TMCI's ROE of -0.49%. Regarding short-term risk, ICCM is more volatile compared to TMCI. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs OM Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, OM has a market cap of 367.4M. Regarding current trading prices, ICCM is priced at $1.02, while OM trades at $20.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas OM's P/E ratio is -0.72. In terms of profitability, ICCM's ROE is -1.82%, compared to OM's ROE of -1.45%. Regarding short-term risk, ICCM is more volatile compared to OM. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs SENS Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, SENS has a market cap of 361.5M. Regarding current trading prices, ICCM is priced at $1.02, while SENS trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas SENS's P/E ratio is -4.36. In terms of profitability, ICCM's ROE is -1.82%, compared to SENS's ROE of -7.46%. Regarding short-term risk, ICCM is more volatile compared to SENS. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs VREX Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, VREX has a market cap of 355.7M. Regarding current trading prices, ICCM is priced at $1.02, while VREX trades at $8.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas VREX's P/E ratio is -8.32. In terms of profitability, ICCM's ROE is -1.82%, compared to VREX's ROE of -0.08%. Regarding short-term risk, ICCM is more volatile compared to VREX. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs NPCE Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, NPCE has a market cap of 343.7M. Regarding current trading prices, ICCM is priced at $1.02, while NPCE trades at $10.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas NPCE's P/E ratio is -12.78. In terms of profitability, ICCM's ROE is -1.82%, compared to NPCE's ROE of -1.40%. Regarding short-term risk, ICCM is more volatile compared to NPCE. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs NNOX Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, NNOX has a market cap of 326.1M. Regarding current trading prices, ICCM is priced at $1.02, while NNOX trades at $5.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas NNOX's P/E ratio is -5.62. In terms of profitability, ICCM's ROE is -1.82%, compared to NNOX's ROE of -0.31%. Regarding short-term risk, ICCM is more volatile compared to NNOX. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs CLPT Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, CLPT has a market cap of 318.3M. Regarding current trading prices, ICCM is priced at $1.02, while CLPT trades at $11.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas CLPT's P/E ratio is -14.82. In terms of profitability, ICCM's ROE is -1.82%, compared to CLPT's ROE of -0.78%. Regarding short-term risk, ICCM is more volatile compared to CLPT. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs CERS Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, CERS has a market cap of 282.9M. Regarding current trading prices, ICCM is priced at $1.02, while CERS trades at $1.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas CERS's P/E ratio is -14.80. In terms of profitability, ICCM's ROE is -1.82%, compared to CERS's ROE of -0.35%. Regarding short-term risk, ICCM is less volatile compared to CERS. This indicates potentially lower risk in terms of short-term price fluctuations for ICCM.
ICCM vs VMD Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, VMD has a market cap of 276.7M. Regarding current trading prices, ICCM is priced at $1.02, while VMD trades at $7.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas VMD's P/E ratio is 23.33. In terms of profitability, ICCM's ROE is -1.82%, compared to VMD's ROE of +0.10%. Regarding short-term risk, ICCM is more volatile compared to VMD. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs SNWV Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, SNWV has a market cap of 275.7M. Regarding current trading prices, ICCM is priced at $1.02, while SNWV trades at $31.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas SNWV's P/E ratio is -5.17. In terms of profitability, ICCM's ROE is -1.82%, compared to SNWV's ROE of +1.00%. Regarding short-term risk, ICCM is more volatile compared to SNWV. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs ZIMV Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, ZIMV has a market cap of 274.7M. Regarding current trading prices, ICCM is priced at $1.02, while ZIMV trades at $10.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas ZIMV's P/E ratio is -10.93. In terms of profitability, ICCM's ROE is -1.82%, compared to ZIMV's ROE of -0.04%. Regarding short-term risk, ICCM is less volatile compared to ZIMV. This indicates potentially lower risk in terms of short-term price fluctuations for ICCM.
ICCM vs PTHL Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, PTHL has a market cap of 261.2M. Regarding current trading prices, ICCM is priced at $1.02, while PTHL trades at $17.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas PTHL's P/E ratio is -366.60. In terms of profitability, ICCM's ROE is -1.82%, compared to PTHL's ROE of -0.30%. Regarding short-term risk, ICCM is more volatile compared to PTHL. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs QTRX Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, QTRX has a market cap of 259.9M. Regarding current trading prices, ICCM is priced at $1.02, while QTRX trades at $6.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas QTRX's P/E ratio is -5.40. In terms of profitability, ICCM's ROE is -1.82%, compared to QTRX's ROE of -0.15%. Regarding short-term risk, ICCM is more volatile compared to QTRX. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs BWAY Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, BWAY has a market cap of 245.2M. Regarding current trading prices, ICCM is priced at $1.02, while BWAY trades at $12.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas BWAY's P/E ratio is 58.98. In terms of profitability, ICCM's ROE is -1.82%, compared to BWAY's ROE of +0.06%. Regarding short-term risk, ICCM is more volatile compared to BWAY. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs CATX Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, CATX has a market cap of 242.7M. Regarding current trading prices, ICCM is priced at $1.02, while CATX trades at $3.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas CATX's P/E ratio is -2.66. In terms of profitability, ICCM's ROE is -1.82%, compared to CATX's ROE of -0.27%. Regarding short-term risk, ICCM is less volatile compared to CATX. This indicates potentially lower risk in terms of short-term price fluctuations for ICCM.
ICCM vs TCMD Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, TCMD has a market cap of 237.8M. Regarding current trading prices, ICCM is priced at $1.02, while TCMD trades at $10.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas TCMD's P/E ratio is 15.50. In terms of profitability, ICCM's ROE is -1.82%, compared to TCMD's ROE of +0.08%. Regarding short-term risk, ICCM is more volatile compared to TCMD. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs MASS Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, MASS has a market cap of 232.4M. Regarding current trading prices, ICCM is priced at $1.02, while MASS trades at $6.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas MASS's P/E ratio is -2.92. In terms of profitability, ICCM's ROE is -1.82%, compared to MASS's ROE of -0.13%. Regarding short-term risk, ICCM is more volatile compared to MASS. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs MXCT Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, MXCT has a market cap of 230.7M. Regarding current trading prices, ICCM is priced at $1.02, while MXCT trades at $2.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas MXCT's P/E ratio is -5.42. In terms of profitability, ICCM's ROE is -1.82%, compared to MXCT's ROE of -0.20%. Regarding short-term risk, ICCM is more volatile compared to MXCT. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs BSGM Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, BSGM has a market cap of 227.1M. Regarding current trading prices, ICCM is priced at $1.02, while BSGM trades at $9.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas BSGM's P/E ratio is -15.70. In terms of profitability, ICCM's ROE is -1.82%, compared to BSGM's ROE of -35.30%. Regarding short-term risk, ICCM is less volatile compared to BSGM. This indicates potentially lower risk in terms of short-term price fluctuations for ICCM.
ICCM vs NVRO Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, ICCM is priced at $1.02, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas NVRO's P/E ratio is -1.91. In terms of profitability, ICCM's ROE is -1.82%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, ICCM is more volatile compared to NVRO. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs SGHT Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, SGHT has a market cap of 210.4M. Regarding current trading prices, ICCM is priced at $1.02, while SGHT trades at $4.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas SGHT's P/E ratio is -4.15. In terms of profitability, ICCM's ROE is -1.82%, compared to SGHT's ROE of -0.55%. Regarding short-term risk, ICCM is more volatile compared to SGHT. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs EYES Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, EYES has a market cap of 210M. Regarding current trading prices, ICCM is priced at $1.02, while EYES trades at $4.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas EYES's P/E ratio is N/A. In terms of profitability, ICCM's ROE is -1.82%, compared to EYES's ROE of -0.26%. Regarding short-term risk, ICCM is more volatile compared to EYES. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs TLSI Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, TLSI has a market cap of 195.6M. Regarding current trading prices, ICCM is priced at $1.02, while TLSI trades at $5.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas TLSI's P/E ratio is -4.68. In terms of profitability, ICCM's ROE is -1.82%, compared to TLSI's ROE of +1.04%. Regarding short-term risk, ICCM is more volatile compared to TLSI. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs INGN Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, INGN has a market cap of 190.9M. Regarding current trading prices, ICCM is priced at $1.02, while INGN trades at $7.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas INGN's P/E ratio is -6.17. In terms of profitability, ICCM's ROE is -1.82%, compared to INGN's ROE of -0.15%. Regarding short-term risk, ICCM is more volatile compared to INGN. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs PROF Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, PROF has a market cap of 183.4M. Regarding current trading prices, ICCM is priced at $1.02, while PROF trades at $6.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas PROF's P/E ratio is -5.04. In terms of profitability, ICCM's ROE is -1.82%, compared to PROF's ROE of -0.70%. Regarding short-term risk, ICCM is more volatile compared to PROF. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs ELMD Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, ELMD has a market cap of 181.5M. Regarding current trading prices, ICCM is priced at $1.02, while ELMD trades at $20.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas ELMD's P/E ratio is 27.39. In terms of profitability, ICCM's ROE is -1.82%, compared to ELMD's ROE of +0.17%. Regarding short-term risk, ICCM is less volatile compared to ELMD. This indicates potentially lower risk in terms of short-term price fluctuations for ICCM.
ICCM vs CVRX Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, CVRX has a market cap of 157.5M. Regarding current trading prices, ICCM is priced at $1.02, while CVRX trades at $6.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas CVRX's P/E ratio is -2.82. In terms of profitability, ICCM's ROE is -1.82%, compared to CVRX's ROE of -0.79%. Regarding short-term risk, ICCM is less volatile compared to CVRX. This indicates potentially lower risk in terms of short-term price fluctuations for ICCM.
ICCM vs RPID Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, RPID has a market cap of 153M. Regarding current trading prices, ICCM is priced at $1.02, while RPID trades at $3.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas RPID's P/E ratio is -3.39. In terms of profitability, ICCM's ROE is -1.82%, compared to RPID's ROE of -0.56%. Regarding short-term risk, ICCM is less volatile compared to RPID. This indicates potentially lower risk in terms of short-term price fluctuations for ICCM.
ICCM vs LNSR Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, LNSR has a market cap of 152.3M. Regarding current trading prices, ICCM is priced at $1.02, while LNSR trades at $12.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas LNSR's P/E ratio is -2.63. In terms of profitability, ICCM's ROE is -1.82%, compared to LNSR's ROE of -5.28%. Regarding short-term risk, ICCM is more volatile compared to LNSR. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs ANIK Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, ANIK has a market cap of 151M. Regarding current trading prices, ICCM is priced at $1.02, while ANIK trades at $11.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas ANIK's P/E ratio is -14.04. In terms of profitability, ICCM's ROE is -1.82%, compared to ANIK's ROE of -0.33%. Regarding short-term risk, ICCM is less volatile compared to ANIK. This indicates potentially lower risk in terms of short-term price fluctuations for ICCM.
ICCM vs RCEL Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, RCEL has a market cap of 139.3M. Regarding current trading prices, ICCM is priced at $1.02, while RCEL trades at $5.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas RCEL's P/E ratio is -2.41. In terms of profitability, ICCM's ROE is -1.82%, compared to RCEL's ROE of -3.38%. Regarding short-term risk, ICCM is more volatile compared to RCEL. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs AVR Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, AVR has a market cap of 138.7M. Regarding current trading prices, ICCM is priced at $1.02, while AVR trades at $3.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas AVR's P/E ratio is -1.07. In terms of profitability, ICCM's ROE is -1.82%, compared to AVR's ROE of -2.92%. Regarding short-term risk, ICCM is less volatile compared to AVR. This indicates potentially lower risk in terms of short-term price fluctuations for ICCM.
ICCM vs OWLT Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, OWLT has a market cap of 138.5M. Regarding current trading prices, ICCM is priced at $1.02, while OWLT trades at $8.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas OWLT's P/E ratio is -5.20. In terms of profitability, ICCM's ROE is -1.82%, compared to OWLT's ROE of +1.25%. Regarding short-term risk, ICCM is more volatile compared to OWLT. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs BDMD Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, BDMD has a market cap of 137.9M. Regarding current trading prices, ICCM is priced at $1.02, while BDMD trades at $3.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas BDMD's P/E ratio is 7.88. In terms of profitability, ICCM's ROE is -1.82%, compared to BDMD's ROE of +0.12%. Regarding short-term risk, ICCM is less volatile compared to BDMD. This indicates potentially lower risk in terms of short-term price fluctuations for ICCM.
ICCM vs LUCD Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, LUCD has a market cap of 119M. Regarding current trading prices, ICCM is priced at $1.02, while LUCD trades at $1.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas LUCD's P/E ratio is -0.94. In terms of profitability, ICCM's ROE is -1.82%, compared to LUCD's ROE of +26.96%. Regarding short-term risk, ICCM is more volatile compared to LUCD. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs LUNG Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, LUNG has a market cap of 108.3M. Regarding current trading prices, ICCM is priced at $1.02, while LUNG trades at $2.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas LUNG's P/E ratio is -1.87. In terms of profitability, ICCM's ROE is -1.82%, compared to LUNG's ROE of -0.64%. Regarding short-term risk, ICCM is more volatile compared to LUNG. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs ICAD Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, ICAD has a market cap of 102.2M. Regarding current trading prices, ICCM is priced at $1.02, while ICAD trades at $3.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas ICAD's P/E ratio is -19.58. In terms of profitability, ICCM's ROE is -1.82%, compared to ICAD's ROE of -0.17%. Regarding short-term risk, ICCM is more volatile compared to ICAD. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.
ICCM vs MGRM Comparison
ICCM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCM stands at 57.7M. In comparison, MGRM has a market cap of 102.1M. Regarding current trading prices, ICCM is priced at $1.02, while MGRM trades at $2.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCM currently has a P/E ratio of -3.64, whereas MGRM's P/E ratio is -5.72. In terms of profitability, ICCM's ROE is -1.82%, compared to MGRM's ROE of -1.26%. Regarding short-term risk, ICCM is more volatile compared to MGRM. This indicates potentially higher risk in terms of short-term price fluctuations for ICCM.